60 DEGREES PHARMACEUTICALS, INC. Cash Flow Statement
SXTP|3 years of annual SEC 10-K data (FY2023-FY2025)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 3 fiscal years. All figures from audited SEC 10-K filings.
60 DEGREES PHARMACEUTICALS, INC. used $6M in operating cash flow and negative free cash flow of $6M in FY2025.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -4.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income | -$7.9M | -$3.8M | -$6.2M |
| Depreciation & Amortization | $11.7K | $21.2K | $27.6K |
| Operating Cash Flow | -$5.6M | -$4.5M | -$1.0M |
| Capital Expenditures | $103.8K | $57.6K | $57.6K |
| Free Cash Flow | -$5.8M | -$4.6M | -$1.1M |
| FCF Margin | -946.7% | -1814.3% | -478.3% |